NO893088D0 - Fremgangsmaate for fremstilling av terapeutisk virksomme somatostatinlignende cykliske peptidforbindelser. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk virksomme somatostatinlignende cykliske peptidforbindelser.

Info

Publication number
NO893088D0
NO893088D0 NO893088A NO893088A NO893088D0 NO 893088 D0 NO893088 D0 NO 893088D0 NO 893088 A NO893088 A NO 893088A NO 893088 A NO893088 A NO 893088A NO 893088 D0 NO893088 D0 NO 893088D0
Authority
NO
Norway
Prior art keywords
somatostat
peptid
relations
procedure
preparation
Prior art date
Application number
NO893088A
Other languages
English (en)
Other versions
NO893088L (no
Inventor
John J Nestor
Brian H Vickery
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of NO893088D0 publication Critical patent/NO893088D0/no
Publication of NO893088L publication Critical patent/NO893088L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO89893088A 1988-08-18 1989-07-31 Fremgangsmaate for fremstilling av terapeutisk virksomme somatostatinlignende cykliske peptidforbindelser. NO893088L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23369088A 1988-08-18 1988-08-18

Publications (2)

Publication Number Publication Date
NO893088D0 true NO893088D0 (no) 1989-07-31
NO893088L NO893088L (no) 1990-02-19

Family

ID=22878305

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89893088A NO893088L (no) 1988-08-18 1989-07-31 Fremgangsmaate for fremstilling av terapeutisk virksomme somatostatinlignende cykliske peptidforbindelser.

Country Status (11)

Country Link
EP (1) EP0363589A3 (no)
JP (1) JPH0273100A (no)
KR (1) KR900003205A (no)
AU (1) AU3926589A (no)
DK (1) DK375789A (no)
FI (1) FI893643A (no)
HU (1) HUT50487A (no)
IL (1) IL91166A0 (no)
NO (1) NO893088L (no)
PT (1) PT91384A (no)
ZA (1) ZA895838B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985240A (en) * 1989-08-09 1999-11-16 Rhomed Incorporated Peptide radiopharmaceutical applications
DK0450480T3 (da) * 1990-04-06 1995-08-14 Univ Tulane Somatostatinaloger
DE69229436T2 (de) * 1991-02-08 1999-11-25 Biomeasure, Inc. Verwendung von somatostatinanalogen zur behandlung von melanomen
US5504069A (en) * 1993-02-11 1996-04-02 Biomeasure, Inc. Inhibition of trauma-induced tumor growth
DE69435105D1 (de) 1993-08-09 2008-08-07 Sod Conseils Rech Applic Derivate therapeutischer Peptide
US5597894A (en) * 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
NZ314406A (en) * 1996-03-18 2000-12-22 Sankyo Co Treatment or prophylaxis of pancreatitis with a medicament containing an insulin sensitiser including oxazoles and thiazoles
CA2289499C (en) * 1997-05-13 2010-02-23 Michael Anthony Cawthorne Somatostatin and somatostatin agonists for treating insulin insensitivity and syndrome x
WO1998051330A1 (en) 1997-05-13 1998-11-19 Societe De Conseils De Recherches Et D'applications Scientifiques S.A. (S.C.R.A.S.) Method and compositions for treating hyperlipidemia and other conditions
PT981363E (pt) 1997-05-13 2003-12-31 Conseils De Rec Appl Scient S Somatostatina e agonistas da somatostatina para reduzir o peso corporal
US6004928A (en) * 1997-05-13 1999-12-21 Biomeasure, Incorporated Method of treating hyperlipidemia
US5968903A (en) * 1998-05-07 1999-10-19 Biomeasure, Incorporated Inhibition of H. pylori proliferation
NZ530007A (en) 2001-06-08 2006-02-24 Sod Conseils Rech Applic Somatostatin-dopamine chimeric analogues that retain both somatostatin and dopamine activity in vivo and display enhanced biological activity
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
NZ576739A (en) 2003-04-22 2011-01-28 Sod Conseils Rech Applic Peptide vectors for delivering paclitaxel
CN107446053A (zh) 2008-06-12 2017-12-08 益普生生物创新有限公司 癌症的抑制
EP2310028B1 (en) 2008-06-12 2016-11-16 Ipsen Bioinnovation Limited Fusion proteins for use in the treatment of acromegaly
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
WO2014197938A1 (en) 2013-06-13 2014-12-18 Antisense Therapeutics Ltd Combination therapy
CN108174843B (zh) * 2018-01-24 2018-11-13 广州市进德生物科技有限公司 一种胰高血糖素保护剂及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4372884A (en) * 1975-08-06 1983-02-08 The Salk Institute For Biological Studies Pharmaceutically active peptides
CH621770A5 (en) * 1976-02-23 1981-02-27 Sandoz Ag Process for the preparation of novel peptide compounds
BE883608A (fr) * 1979-06-11 1980-12-03 Lilly Co Eli Peptides apparentes a la somatostatine leur preparation et leur utilisation therapeutique
CY1327A (en) * 1979-11-27 1986-06-27 Sandoz Ag Novel polypeptides,processes for their production,pharmaceutical compositions comprising said polypeptides and their use
GR862206B (en) * 1985-09-12 1986-12-31 Univ Tulane Therapeutic somatostatin analogs

Also Published As

Publication number Publication date
FI893643A (fi) 1990-02-19
DK375789A (da) 1990-02-19
FI893643A0 (fi) 1989-08-01
EP0363589A2 (en) 1990-04-18
DK375789D0 (da) 1989-07-31
ZA895838B (en) 1991-03-27
NO893088L (no) 1990-02-19
HUT50487A (en) 1990-02-28
KR900003205A (ko) 1990-03-26
PT91384A (pt) 1990-03-08
AU3926589A (en) 1990-02-22
IL91166A0 (en) 1990-03-19
EP0363589A3 (en) 1990-08-16
JPH0273100A (ja) 1990-03-13

Similar Documents

Publication Publication Date Title
NO894842D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazoler.
NO893088L (no) Fremgangsmaate for fremstilling av terapeutisk virksomme somatostatinlignende cykliske peptidforbindelser.
NO900032D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazol-forbindelser.
NO903941D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-derivater.
NO864110L (no) Fremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater.
NO885454D0 (no) Fremgangsmaate for fremstilling av triklormonosilan.
NO894210L (no) Fremgangsmaate for fremstilling av kinolyloxazol-2-oner.
NO893329D0 (no) Fremgangsmaate for fremstilling av titanoksyd.
NO895032L (no) Fremgangsmaate for fremstilling av 2-benzotiazoliner.
NO894949D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzopyranylpyrrolinonderivater.
NO882856D0 (no) Fremgangsmaate for fremstilling av immunoundertrykkende peptider.
NO890159L (no) Fremgangsmaate for fremstilling av 1-alkyl-5-nitroimidazoler.
NO893794D0 (no) Fremgangsmaate for fremstilling av forbedret hydrolysert protein.
NO304428B1 (no) AnalogifremgangsmÕte for fremstilling av terapeutisk aktive vinylazoler
NO168477C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kondenserte diazepinoner.
NO891574D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser.
NO892871D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO895040L (no) Fremgangsmaate for fremstilling av polyhydroxybenzyloxypropanolaminer.
NO903397L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme derivater av protocatechualdehyd.
NO892469D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-forbindelser.
NO904678L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzylpyrrolidenderivater.
NO881036L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme nafthalenderivater.
NO895233D0 (no) Fremgangsmaate for fremstilling av di- og tripeptidderivater.
NO863225D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzodioxepaner.
NO164479C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive peptidforbindelser.